Overview
Yiqun Li practices practicing medicine in Beijing, China.
Their clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Lung Metastases, and Metastatic Brain Tumor.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yiqun Li
Is Yiqun Li a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Yiqun Li is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yiqun Li participate in research or clinical trials?
Yes. Yiqun Li has published 21 articles and abstracts on conditions like Breast Cancer. You can view a list of Yiqun Li's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Interstitial Pneumonia
- Breast CancerLi isExperienced. Learn about Breast Cancer.
- DiarrheaLi isExperienced. Learn about Diarrhea.
- Interstitial Lung Disease
- Lung MetastasesLi isExperienced. Learn about Lung Metastases.
- Metastatic Brain TumorLi isExperienced. Learn about Metastatic Brain Tumor.
- Triple-Negative Breast Cancer